Dear Ms Thibord,

I hereby acknowledge receipt of your e-mail of 25 November 2022 submitted
via the AsktheEU.org website, by means of which you requested access to
“information and documents on the following subject-matters:

According to a study published in 2020 ([1]M. Petek et al., Validating the
Potential of Double-Stranded RNA Targeting Colorado Potato Beetle Mesh
Gene in Laboratory and Field Trials, Frontiers, in Plants Science, 19
August 2020), a field trial of ds-RNA pesticides was conducted in June and
July 2019 on three locations near Ljubljana, in Slovenia. As part of this
trial, DsRNA pesticides were sprayed on fields of potato plants infested
by Colorado potato beetle (CPB) larvae, thus resulting in the release of
GMOs into the environment.

Please confirm whether these trials have been notified and/or authorised
under Directive 2001/18/EC of 12 March 2001 on the deliberate release into
the environment of genetically modified organisms. If not, please indicate
which legislation is relevant and/or applicable for such field trials.”

You highlight that you are requesting access to “all documents (within the
meaning of Regulation 1049/2001) and/or all environmental information
(within the meaning of Regulation 1367/2006), in relation to these trials
and their notification/authorisation process”

Your application for public access to documents (PAD) has been registered
as PAD 2022/166 and is being processed as quickly as possible in
accordance with [2]Regulation (EC) No 1049/2001 regarding public access to
documents (hereinafter “the PAD Regulation”).

We will come back to you by 16 December 2022 at the latest.

We would like to inform you that the AsktheEU.org website you have used
for submitting your request is a third-party platform, with no link to the
institutions, agencies and bodies of the EU, including EFSA. Consequently,
EFSA cannot be held liable for any errors of any kind occurring as a
result of the use of this platform. Likewise, we would like to inform you
that your e-mail address will be used for the further processing of your
application for access to documents.

Additionally, please note that the third party running the AsktheEU.org
website is responsible for the processing of your personal data by means
of this platform. For further information, including on the way the third
party addresses your rights in the light of applicable data protection
legislation, please refer to the third party’s privacy policy. From our
experience with the way the platform operates, we understand that the
content of public access to documents applicants correspondence with EFSA
is usually published on the platform, including any personal data which
may be contained therein (e.g. private postal addresses). Please contact
us directly should you not wish your correspondence with EFSA to be
published on the AsktheEU.org platform. In the event that such a
communication is received from you, EFSA will then redirect all future
electronic correspondence to your private e-mail address only.

Yours sincerely,

Mariama Mesnaoui

EFSA Public Access to documents

EFSA Legal Affairs Services

[3]Description: cid:image001.jpg@01CF4F1E.E87FB350

Via Carlo Magno 1A

IT-43126 Parma
Italy

Tel. +39 0521036264 
[4][email address] 
[5]www.efsa.europa.eu

[6]twitter.com/EFSA_EU [7]Twitter_logo_blue

[8]youtube.com/EFSAchannel [9]YouTube-logo-full_color

[10]linkedin.com/company/efsa [11][IMG]

This e-mail, including its attachments, is intended only for the use of
the recipient(s) named above. Unless you are a named recipient (or
authorized by a recipient), access to this e-mail message or any
disclosure or copying of its content, or any action taken in reliance on
it is unauthorized and may be unlawful.  If you are not the intended
recipient, please let the sender know immediately.

show quoted sections

Dear Ms Thibord,

Further to our e-mail of 28 November 2022, by means of which we
acknowledged receipt of your application for public access to documents
(hereinafter “PAD application”) registered as PAD 2022/166, we would like
to reiterate that your PAD application is being processed as quickly as
possible in accordance with the provisions of [1]Regulation (EC) No
1049/2001 regarding public access to documents (hereinafter “the PAD
Regulation”).

However, we regret to inform you that EFSA is still gathering all the
necessary elements to reply to your PAD application and we therefore have
to extend the deadline by 15 working days in accordance with Article 7(3)
of the PAD Regulation. Please accept our apologies for any inconvenience
this delay may cause.

We will come back to you by 17 January 2023 at the latest.

Yours sincerely,

Mariama Mesnaoui

EFSA Public Access to documents

EFSA Legal Affairs Services

[2]Description: cid:image001.jpg@01CF4F1E.E87FB350

Via Carlo Magno 1A

IT-43126 Parma
Italy

Tel. +39 0521036264 
[3][email address] 
[4]www.efsa.europa.eu

[5]twitter.com/EFSA_EU [6]Twitter_logo_blue

[7]youtube.com/EFSAchannel [8]YouTube-logo-full_color

[9]linkedin.com/company/efsa [10][IMG]

This e-mail, including its attachments, is intended only for the use of
the recipient(s) named above. Unless you are a named recipient (or
authorized by a recipient), access to this e-mail message or any
disclosure or copying of its content, or any action taken in reliance on
it is unauthorized and may be unlawful.  If you are not the intended
recipient, please let the sender know immediately.

From: MESNAOUI Mariama <[11][email address]> On Behalf Of
EFSA.public.access.to.documents
Sent: Monday 28 November 2022 15:21
To: [12][FOI #12232 email]
Cc: EFSA.public.access.to.documents
<[13][email address]>
Subject: PAD 2022/166_Acknowledgement of receipt_Your application for
public access to documents of 25 November 2022

Dear Ms Thibord,

I hereby acknowledge receipt of your e-mail of 25 November 2022 submitted
via the AsktheEU.org website, by means of which you requested access to
“information and documents on the following subject-matters:

According to a study published in 2020 ([14]M. Petek et al., Validating
the Potential of Double-Stranded RNA Targeting Colorado Potato Beetle Mesh
Gene in Laboratory and Field Trials, Frontiers, in Plants Science, 19
August 2020), a field trial of ds-RNA pesticides was conducted in June and
July 2019 on three locations near Ljubljana, in Slovenia. As part of this
trial, DsRNA pesticides were sprayed on fields of potato plants infested
by Colorado potato beetle (CPB) larvae, thus resulting in the release of
GMOs into the environment.

Please confirm whether these trials have been notified and/or authorised
under Directive 2001/18/EC of 12 March 2001 on the deliberate release into
the environment of genetically modified organisms. If not, please indicate
which legislation is relevant and/or applicable for such field trials.”

You highlight that you are requesting access to “all documents (within the
meaning of Regulation 1049/2001) and/or all environmental information
(within the meaning of Regulation 1367/2006), in relation to these trials
and their notification/authorisation process”

Your application for public access to documents (PAD) has been registered
as PAD 2022/166 and is being processed as quickly as possible in
accordance with [15]Regulation (EC) No 1049/2001 regarding public access
to documents (hereinafter “the PAD Regulation”).

We will come back to you by 16 December 2022 at the latest.

We would like to inform you that the AsktheEU.org website you have used
for submitting your request is a third-party platform, with no link to the
institutions, agencies and bodies of the EU, including EFSA. Consequently,
EFSA cannot be held liable for any errors of any kind occurring as a
result of the use of this platform. Likewise, we would like to inform you
that your e-mail address will be used for the further processing of your
application for access to documents.

Additionally, please note that the third party running the AsktheEU.org
website is responsible for the processing of your personal data by means
of this platform. For further information, including on the way the third
party addresses your rights in the light of applicable data protection
legislation, please refer to the third party’s privacy policy. From our
experience with the way the platform operates, we understand that the
content of public access to documents applicants correspondence with EFSA
is usually published on the platform, including any personal data which
may be contained therein (e.g. private postal addresses). Please contact
us directly should you not wish your correspondence with EFSA to be
published on the AsktheEU.org platform. In the event that such a
communication is received from you, EFSA will then redirect all future
electronic correspondence to your private e-mail address only.

Yours sincerely,

Mariama Mesnaoui

EFSA Public Access to documents

EFSA Legal Affairs Services

[16]Description: cid:image001.jpg@01CF4F1E.E87FB350

Via Carlo Magno 1A

IT-43126 Parma
Italy

Tel. +39 0521036264 
[17][email address] 
[18]www.efsa.europa.eu

[19]twitter.com/EFSA_EU [20]Twitter_logo_blue

[21]youtube.com/EFSAchannel [22]YouTube-logo-full_color

[23]linkedin.com/company/efsa [24][IMG]

This e-mail, including its attachments, is intended only for the use of
the recipient(s) named above. Unless you are a named recipient (or
authorized by a recipient), access to this e-mail message or any
disclosure or copying of its content, or any action taken in reliance on
it is unauthorized and may be unlawful.  If you are not the intended
recipient, please let the sender know immediately.

show quoted sections

Dear Ms Thibord,

Please find attached a letter of reply referenced 28502709 from Ms Luisa
Venier for EFSA Public Access to Documents.

Yours sincerely,

Mariama MESNAOUI

Technical Assitant

EFSA Public Access to Documents

[1][email address]

[2]www.efsa.europa.eu

[3][IMG][4][IMG][5][IMG][6][IMG]

This e-mail, including its attachments, is intended only for the use of
the recipient(s) named above. Unless you are a named recipient (or
authorized by a recipient), access to this e-mail message or any
disclosure or copying of its content, or any action taken in reliance on
it is unauthorized and may be unlawful.  If you are not the intended
recipient, please let the sender know immediately.

References

Visible links
1. mailto:[email address]
2. https://eur03.safelinks.protection.outlo...
3. https://eur03.safelinks.protection.outlo...
4. https://eur03.safelinks.protection.outlo...
5. https://eur03.safelinks.protection.outlo...
6. https://eur03.safelinks.protection.outlo...